A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

Clinical trial NCT07089888 · RECRUITING

Trial details

NCT number: NCT07089888
Sponsor: Crystalys Therapeutics
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Tophaceous Gout

Start date: 2025-08-04
Primary completion: 2027-12-31
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.